3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Myelodysplastic Syndromes
3
Lymphoma, Non-Hodgkin
3
Leukemia, Myeloid, Acute
3
Lymphoma
2
Hodgkin Disease
2
Anemia, Refractory, with Excess of Blasts
2
Recurrence
1
Neoplasms
1
Myeloproliferative Disorders
1
Myelodysplastic-Myeloproliferative Diseases
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Chronic-Phase
1
Leukemia, Myeloid, Accelerated Phase
1
Leukemia, Biphenotypic, Acute
1
Leukemia
1
Hemoglobinopathies
1
Graft vs Host Disease
1
Burkitt Lymphoma
1
Bone Marrow Failure Disorders
1
Interventions
X-Rays
6
Phantoms, Imaging
6
Magnetic Resonance Spectroscopy
6
Specimen Handling
5
Nuclear Medicine Department, Hospital
5
Biopsy
4
ulixertinib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
palbociclib
2
larotrectinib
2
ivosidenib
2
erdafitinib
2
ensartinib
2
LY3023414
2
trametinib
1
olaparib
1
dabrafenib
1
Vemurafenib
1
Pharmacogenomic Variants
1
Genetic Testing
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Histiocytosis, Langerhans-Cell
×
Clofarabine
×
90 days
×
Clear all
No trials found.